What is Lotus Bio-Technology Development Enterprise Value?
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Lotus Bio-Technology Development Enterprise Value Chart
Competitive Comparison of Lotus Bio-Technology Development's Enterprise Value
For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Bio-Technology Development's Enterprise Value Distribution in the Agriculture Industry
For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Lotus Bio-Technology Development's Enterprise Value falls into.
Lotus Bio-Technology Development Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Bio-Technology Development (OTCPK:LBTD) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Lotus Bio-Technology Development's EV-to-EBIT for today is
Lotus Bio-Technology Development's current Enterprise Value is $11.74 Mil.
Lotus Bio-Technology Development's EBIT for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Lotus Bio-Technology Development's EV-to-EBITDA for today is:
Lotus Bio-Technology Development's current Enterprise Value is $11.74 Mil.
Lotus Bio-Technology Development's EBITDA for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.
Lotus Bio-Technology Development's current Enterprise Value is $11.74 Mil.
Lotus Bio-Technology Development's Revenue for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Bio-Technology Development Enterprise Value Related Terms
Thank you for viewing the detailed overview of Lotus Bio-Technology Development's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Lotus Bio-Technology Development (Lotus Bio-Technology Development) Business Description
Lotus Bio-Technology Development Corp is a biotechnology development company. It focuses on specializing in the refining of organic materials and the production of natural consumer-related products. It is exploring opportunities in the organic growth and farming sector in China and provides local customers the real organic food products with affordable prices and guarantees that all of them will be produced in an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones, or other dangerous chemicals. All the operation is primarily functioned through the region of China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LBTD has been successfully added to your 